Abstract
Tumors of the central nervous system (CNS) are a remarkably diverse group of neoplasms and the diversity of their origins is reflected in their biological behavior and clinical manifestations. Primary CNS tumors occur infrequently compared to other tumor types, yet approximately 15,000–20,000 Americans are afflicted each year. In contrast to the relative rarity of these tumors in adults, brain tumors are the second most common type of tumor seen during childhood occurring with an incidence of 2.2–2.5 cases per 100,000 children per year. The incidence of brain tumors wanes during early adulthood, although they again occur with increasing frequency in the fourth decade of life, after which the incidence continues to increase. The incidence of brain tumors in the elderly is rising, although the reason for this is unknown.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Selected References
Bishop JM. Molecular themes in oncogenesis. Cell 1991; 64: 235–248.
Black PM. Brain tumors. N Engl J Med 1991; 324: 1471–1476.
Fick J, Israel MA. Gene therapy for diseases of the nervous system. West J Med 1994; 161: 260–263.
Hamilton SR, Liu B, Parsons RE, et al. The molecular basis of Turcot’s syndrome. N Engl J Med 1995; 332: 839–847.
James CD, Mikkelsen T, Cavenee WK, Collins VP. Molecular genetic aspects of glial tumour evolution. Cancer Sury 1990; 9: 631–644.
Kleihues P, Burger PC, Scheithauer BW, in collaboration with L. H. Sorbin and pathologists in 14 countries. Histological Typing of Tumours of the Central Nervous System, 2nd ed. Springer-Verlag, New York, 1993.
Knudson AG. Mutation and cancer: statistical study of retinoblastoma. Proc Natl Acad Sci USA 1971; 68: 820–824.
Li J, Yen C, Liaw D, et al. PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science 1997; 275: 1943–1947.
Malkin D, Li FP, Strong LC, et al. Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms. Science 1990; 250: 1233–1238.
Marchuk DA, Collins FS. Molecular genetics of neurofibromatosis 1. In: The Neurofibromatoses: A Pathogenetic and Clinical Overview. Eds. Huson SM, Hughes RAC. Chapman & Hall Medical, London, 1994, pp. 23–44.
Miller BA, Gloeckler R, Lynn A, et al. Seer Cancer Statistics Review 1973–1990. Department of Health and Human Services, Public Health Service, NIH, NCI Bethesda, MD, 1993.
van Slegtenhorst M, de Hoogt R, Hermans C, et al. Identification of the tuberous sclerosis gene TSC1 on chromosome 9q34. Science 1997; 277: 805–808.
Wen PY, Schiff D. Clinical evaluation of patients with astrocytomas. In: Black P McL, Schoene WC, Lampson LA, eds. Astrocytomas: Diagnosis, Treatment, and Biology. Boston: Blackwell, 1993, pp. 26–29.
Zülch KJ. Brain Tumors: Their Biology and Pathology, vol. 3. Berlin: Springer-Verlag, 1986, pp. 1–323.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1998 Springer Science+Business Media New York
About this chapter
Cite this chapter
Israel, M.A. (1998). Brain Tumors. In: Jameson, J.L. (eds) Principles of Molecular Medicine. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-59259-726-0_107
Download citation
DOI: https://doi.org/10.1007/978-1-59259-726-0_107
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-4757-6272-3
Online ISBN: 978-1-59259-726-0
eBook Packages: Springer Book Archive